Clinical Trial Update: A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjunctive prednisolone plus Mycobacterium w immunotherapy for tuberculous pericarditis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Pericarditis

Drugs mentioned

• Mycobacterium w immunotherapy (Mycobacterium w (Mw) immunotherapy)
• Prednisolone (Prednisolone)

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculous Pericarditis | Phase 3 | Status: COMPLETED